PATENT CLAIM ANALYSIS

Application Number: 16239531
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-12
Patent Classification: ["514", "449000"]

Abstract:
Disclosed herein are compositions and methods for treating kidney tumors by intratumoral injection administration of compositions comprising taxane particles such as docetaxel particles or paclitaxel particles.

Claim (Index 13):
The method of  claim 1 , wherein, the docetaxel particles are not bound to, encapsulated in, or coated with one or more of a monomer, a polymer (or biocompatible polymer), a protein, a surfactant, or albumin.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16007095', '16136502', '15895197', '15174505', '12872156']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7380016668669497
- 35 USC 102 Novelty (BERT): 0.5248328262757259
- Combined Prediction Score: 0.7166847828078273
- Mean Citation Score: 213.92878
- Max Citation Score: 248.25058
- Similarity Product: 159.88825765008568

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test